Article Details
Retrieved on: 2024-10-31 18:28:23
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses a study on lecanemab's benefits for early-stage Alzheimer's patients, showing symptom improvement and no decline. It highlights lecanemab's potential impact on disease progression, discussed at a Madrid conference.
Article found on: www.patientcareonline.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here